UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Strategic Advisors LLC

Strategic Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 6,291 shares of the healthcare conglomerate’s stock after buying an additional 212 shares during the quarter. Strategic Advisors LLC’s holdings in UnitedHealth Group were worth $3,182,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of UNH. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the period. Accredited Investors Inc. increased its holdings in shares of UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares in the last quarter. State Street Corp increased its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $276,785,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $523.48 on Monday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company’s 50 day simple moving average is $523.11 and its 200 day simple moving average is $563.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.